* Advaxis reports business update and third quarter 2017
July 6 Cancer immunotherapy developer Advaxis
Inc said on Thursday Daniel O'Connor stepped down from
his position as the company's chief executive and its board.
* Advaxis inc - Anthony Lombardo named interim chief
* Company confirmed that it is on track to initiate clinical
studies of ADXS-NEO later this year